Is It Just for a Screening Program to Give People All the Information They Want?
- 12 May 2023
- journal article
- research article
- Published by Taylor & Francis in The American Journal of Bioethics
- Vol. 23 (7) , 34-42
Abstract
Genomic screening at population scale generates many ethical considerations. One is the normative role that people’s preferences should play in determining access to genomic information in screening contexts, particularly information that falls beyond the scope of screening. We expect both that people will express a preference to receive such results and that there will be interest from the professional community in providing them. In this paper, we consider this issue in relation to the just and equitable design of population screening programs like reproductive genetic carrier screening (RGCS). Drawing on a pluralistic public health ethics perspective, we claim that generating and reporting information about genetic variants beyond the scope of the screening program usually lacks clinical, and perhaps personal, utility. There are both pragmatic and ethical reasons to restrict information provision to that which fits the stated purpose of the program.Keywords
This publication has 30 references indexed in Scilit:
- Secondary findings in exome slices, virtual panels, and anticipatory sequencingGenetics in Medicine, 2019
- Too Much of a Good Thing? Overdiagnosis, or Overestimating Risk in Preventive Genomic ScreeningPersonalized Medicine, 2018
- Precision public health—the Emperor’s new clothesInternational Journal of Epidemiology, 2018
- Avoiding the Technological Imperative: Criteria for Genetic Screening ProgramsOBM Genetics, 2017
- Personal utility in genomic testing: a systematic literature reviewEuropean Journal of Human Genetics, 2017
- Known unknowns: building an ethics of uncertainty into genomic medicineBMC Medical Genomics, 2016
- Responsible implementation of expanded carrier screeningEuropean Journal of Human Genetics, 2016
- Personal utility in genomic testing: is there such a thing?Journal of Medical Ethics, 2014
- Genetic Tests: Clinical Validity and Clinical UtilityCurrent Protocols in Human Genetics, 2014
- On the future of genetic risk assessmentJournal of Community Genetics, 2012